Dixon Hughes Goodman Wealth Advisors’s Novavax NVAX Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$53K	Buy	+725	New	+$64.7K	0.02%	305

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's NVAX Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors opened a new position in Novavax (NVAX) in Q1 2022: 725 shares worth $53K. The stake represents 0.02% of the portfolio and ranks #305 among its holdings.

381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 725 shares of Novavax worth $53K as of Q1 2022.
Novavax was a new Dixon Hughes Goodman Wealth Advisors position in Q1 2022.
Novavax made up 0.02% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #305 holding.
381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.